Pune, India -- (SBWire) -- 03/07/2019 --CAR-T cell therapy is the most promising and remarkable treatment in the areas of oncology. It is a treatment that uses cells from a person's own immune system to fight against cancer. CAR-T Cell therapy works on gene transfer technology that enhances the immune response of cancer affected patient by destroying tumor cells. In 2017, two CAR-T Cell therapies were approved by the Food and Drug Administration (FDA), one for the treatment of children with acute lymphoblastic leukemia (ALL) and the other for adults with advanced lymphomas.
Company Coverage of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market: Bluebird Bio, Inc., Celgene Corporation, Novartis International AG & Gilead Sciences
Complete report on "Global CAR T-Cell Therapy Market" with providing 4 company profiles, 13 tables and 47 charts is now available at http://www.marketreportsonline.com/782898.html.
CAR-T Cell market is majorly driven by an increasing number of cancer cases and high demand for effective therapy in this area. The increasing number of products in the clinical pipeline under development would act as a growth catalyst for the global market. The ability of therapy to treat recurrent cancers with high efficiency is also contributing significantly to the market growth.
CD19 is the most targeted antigen for a limited range of blood cancers. Hematological cancers indicate a highly competitive therapy segment as compared to solid tumors, in which it is little difficult to identify the antigens and will offer a vast market potential. With the recent launch of CAR-T cell therapies like Kymriah and Yescarta, the market is estimated to witness robust growth in the upcoming years.
The market exhibit huge potential for companies engaged in developing, manufacturing of CAR T cell therapies for cancer treatment. Upcoming novel products and technologies and the presence of big players in the market will result in intense competition in future.
The report "Global CAR-T Cell Market: Industry Analysis & Outlook (2019-2023)" provides extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering The United States, Europe, and Japan region along with the global market. The report profiles the key players of the market including Novartis International AG, Bluebird Bio, Celgene Corporation and Gilead Sciences.
Purchase a copy of this "Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market" report at USD 1000 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=782898.
Major Points from Table of Contents Covered in Global Chimeric Antigen Receptor (CAR) T-Cell Therapy 2019 Edition Report:
1. Market Overview
1.1 Introduction
1.2 CAR-T Cell Design
1.3 Process of T-Cell Therapy
1.4 Autologous vs. Allogeneic CAR-T cell therapy
1.5 Mechanism of Action
1.6 Toxicity Related to CAR-T Cell Therapy
1.7 FDA Approved CAR-T Cell Therapy
1.8 CAR-T Cell Therapies under Development
2. Global Market Analysis
2.1 Global CAR-T Cell Market Forecast by Value
2.2 Number of CAR-T Cell Clinical Trials
2.3 Number of Clinical Trials Targeting Hematologic Malignancies by Antigens
2.4 Number of Clinical Trials Targeting Solid Tumors by Antigens
2.5 Global CAR-T Cell Hematological Malignancy Market
2.6 Global Kymriah Revenue Forecast
2.7 Global Yescarta Revenue Forecast
2.8 Global CYAD-01 AML Revenue Forecast
2.9 Global CYAD-01 mCRC Revenue Forecast
3. Regional Market Analysis
3.1 The U.S.
3.2 Europe
3.3 Japan
4. Market Dynamics
4.1 Growth Drivers
4.2 Key Trends & Developments
4.3 Challenges
5. Competitive Landscape
5.1 Global Market
6. Company Profiles
Browse all latest pharmaceuticals market research reports at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.
About Market Reports Online
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.
Contact Us:
Vishal Kalra
Tel: + 1 888 391 5441
Email: sales@marketreportsonline.com
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market 2019 Edition Report
MarketReportsOnline.com adds Global Chimeric Antigen Receptor (CAR) T-Cell Therapy: Industry Analysis & Outlook (2019-2023) research report of 93 pages published in February 2019 to the Pharmaceuticals market data collection of its online business intelligence library.